ARRIS International plc (ARRS) Forms $25.77 Double Top; Healthcare Trust America (HTA) Shorts Up By 7.23%

ARRIS International plc (ARRS) formed double top with $27.83 target or 8.00% above today’s $25.77 share price. ARRIS International plc (ARRS) has $4.82 billion valuation. The stock increased 0.31% or $0.08 during the last trading session, reaching $25.77. About 1.40 million shares traded or 8.76% up from the average. ARRIS International plc (NASDAQ:ARRS) has risen 22.70% since January 3, 2017 and is uptrending. It has outperformed by 6.00% the S&P500.

Healthcare Trust America Incorporated (NYSE:HTA) had an increase of 7.23% in short interest. HTA’s SI was 9.01M shares in January as released by FINRA. Its up 7.23% from 8.40 million shares previously. With 915,600 avg volume, 10 days are for Healthcare Trust America Incorporated (NYSE:HTA)’s short sellers to cover HTA’s short positions. The SI to Healthcare Trust America Incorporated’s float is 6.4%. The stock decreased 1.13% or $0.34 during the last trading session, reaching $29.7. About 1.13M shares traded. Healthcare Trust of America, Inc. (NYSE:HTA) has risen 7.80% since January 3, 2017 and is uptrending. It has underperformed by 8.90% the S&P500.

Healthcare Trust of America, Inc. is a publicly owned equity real estate investment trust. The company has market cap of $6.21 billion. The firm invests in the real estate markets of the United States. It has a 130.84 P/E ratio. It is engaged in acquiring, owning and operating high-quality medical office buildings located primarily on-campus or affiliated with the nationÂ’s leading healthcare systems.

Among 12 analysts covering Healthcare Trust of America (NYSE:HTA), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Healthcare Trust of America had 32 analyst reports since August 26, 2015 according to SRatingsIntel. The stock has “Buy” rating by Stifel Nicolaus on Thursday, December 31. The stock of Healthcare Trust of America, Inc. (NYSE:HTA) earned “Outperform” rating by BMO Capital Markets on Tuesday, June 20. BTIG Research initiated Healthcare Trust of America, Inc. (NYSE:HTA) rating on Thursday, August 25. BTIG Research has “Buy” rating and $37 target. As per Tuesday, July 18, the company rating was maintained by BMO Capital Markets. The stock of Healthcare Trust of America, Inc. (NYSE:HTA) has “Buy” rating given on Monday, August 28 by Jefferies. BMO Capital Markets maintained it with “Hold” rating and $33 target in Thursday, April 13 report. The firm earned “Buy” rating on Friday, December 16 by Jefferies. The rating was maintained by Jefferies with “Buy” on Friday, July 7. Oppenheimer maintained Healthcare Trust of America, Inc. (NYSE:HTA) rating on Tuesday, August 2. Oppenheimer has “Outperform” rating and $38 target. The stock has “Buy” rating by TheStreet on Friday, October 16.

Among 13 analysts covering Arris Group Inc. (NASDAQ:ARRS), 10 have Buy rating, 1 Sell and 2 Hold. Therefore 77% are positive. Arris Group Inc. has $42 highest and $25.0 lowest target. $34.91’s average target is 35.47% above currents $25.77 stock price. Arris Group Inc. had 38 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Thursday, August 24 with “Buy”. Barclays Capital maintained ARRIS International plc (NASDAQ:ARRS) rating on Thursday, February 18. Barclays Capital has “Overweight” rating and $37 target. Northland Capital maintained it with “Hold” rating and $28.0 target in Thursday, November 2 report. Morgan Stanley initiated ARRIS International plc (NASDAQ:ARRS) rating on Tuesday, September 20. Morgan Stanley has “Overweight” rating and $34 target. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, February 23. The stock has “Buy” rating by UBS on Wednesday, September 9. The stock of ARRIS International plc (NASDAQ:ARRS) has “Buy” rating given on Tuesday, March 14 by Goldman Sachs. The firm earned “Buy” rating on Friday, December 1 by Raymond James. On Tuesday, December 19 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. Goldman Sachs downgraded ARRIS International plc (NASDAQ:ARRS) rating on Monday, March 14. Goldman Sachs has “Neutral” rating and $26 target.